<unk>  is an Antineoplastic agent and platinum coordination complex that is FDA approved for the treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor, advanced colorectal cancer. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include peripheral sensory neuropathy, neutropenia, thrombocytopenia, anemia, nausea, increase in transaminases and alkaline phosphatase, diarrhea, emesis, fatigue and stomatitis.
Oxaliplatin
Capecitabine
Satraplatin
Carboplatin
Ifosfamide
Zorubicin
Etoposide 
Cisplatin